Stock KROS KEROS THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Keros Therapeutics, Inc.

Equities

KROS

US4923271013

Real-time Estimate Cboe BZX
Other stock markets
 01:59:40 2024-05-29 pm EDT 		5-day change 1st Jan Change
46.96 USD -3.66% Intraday chart for Keros Therapeutics, Inc. -8.37% +17.78%
May. 28 Keros Therapeutics, Inc. Appoints Jean-Jacques Bienaimé to Its Board of Directors, Effective June 1, 2024 CI
May. 08 Earnings Flash (KROS) KEROS THERAPEUTICS Reports Q1 Revenue $83,000 MT

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Wedbush Starts Keros Therapeutics at Outperform With $86 Price Target
MT
BofA Securities Initiates Keros Therapeutics With Buy Rating, $65 Price Target
MT
BofA Securities Starts Keros Therapeutics at Buy With $65 Price Target
MT
Piper Sandler Adjusts Keros Therapeutics' Price Target to $110 From $120, Keeps Overweight Rating
MT
Cowen Starts Keros Therapeutics at Outperform
MT
BTIG Adjusts Price Target on Keros Therapeutics to $105 From $95, Maintains Buy Rating
MT
Truist Securities Starts Keros Therapeutics at Buy With $100 Price Target
MT
BTIG Initiates Coverage on Keros Therapeutics With Buy Rating, $80 Price Target
MT
Piper Sandler Adjusts Keros Therapeutics' Price Target to $120 from $90, Keeps Overweight Rating
MT
KEROS THERAPEUTICS : Jefferies Adjusts Keros Therapeutics PT to $75 From $70, Maintains Buy Rating
MT
KEROS THERAPEUTICS : Piper Sandler Adjusts Keros Therapeutics' Price Target to $95 From $75, Reiterates Overweight Rating
MT
KEROS THERAPEUTICS : HC Wainwright Adjusts Keros Therapeutics' Price Target to $100 From $50, Keeps at Buy
MT
KEROS THERAPEUTICS : SVB Leerink Adjusts Keros Therapeutics' Price Target to $80 from $42, Keeps Outperform Rating
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. KROS Stock
  4. News Keros Therapeutics, Inc.
  5. Analyst Reco.